{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:46:17Z","timestamp":1787168777196,"version":"build-2736575974"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Retin Vitr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To assess the characteristics and outcomes of uveal melanoma management at a tertiary center in the Middle East.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A study on 164 patients with uveal melanoma was conducted by reviewing the available medical records, ultrasound, and pathology report results. Age at diagnosis, tumor location and size, treatment mode, visual outcome, metastasis, mortality, and survival were studied.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The mean age of patients was 52.0\u2009\u00b1\u200915.0 years, and 52.5% were male. Choroidal melanoma was the most common uveal melanoma, followed by the ciliary body and iris melanoma. The mean thickness of tumors was 8.29\u2009\u00b1\u20093.29. The majority of patients (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009111, 67.9%) were managed by brachytherapy with ruthenium-106 plaques. Enucleation was performed primarily in 46 (28%) patients and secondarily in nine (5.5%) patients. The sexual disparity was detected as the proximity of uveal melanoma to the fovea in males. For a 61-month mean follow-up period, mortality occurred in eight of our cases, six of which were due to metastasis. The most common site for distance metastasis was the liver (5\/6), followed by the lung (1\/6). The five-year and eight-year overall survival (OS) rate was 0.947%\u00b1 0.019. The 5-year survival rate reached zero in metastatic patients. OS was not statistically different depending on the age, tumor diameters, the primary treatment received, or the histopathologic findings (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&gt;\u20090.50 for all).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this study, individuals diagnosed with UM exhibited an OS rate of around 94% at the five-year mark, which remained consistent up to eight years. Notably, the presence of distance metastasis emerged as the sole statistically significant factor influencing overall survival.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40942-024-00531-x","type":"journal-article","created":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T04:02:23Z","timestamp":1709265743000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Uveal melanoma in the Iranian population: two decades of patient management in a tertiary eye center"],"prefix":"10.1186","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2277-398X","authenticated-orcid":false,"given":"Hamid","family":"Riazi-Esfahani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahim","family":"Amini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babak","family":"Masoomian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Yaseri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siamak","family":"Sabour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Rashidinia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojtaba","family":"Arjmand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mohsen","family":"Rafizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadkarim","family":"Johari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8123-4375","authenticated-orcid":false,"given":"Elias","family":"Khalili Pour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9423-9650","authenticated-orcid":false,"given":"Fariba","family":"Ghassemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,1]]},"reference":[{"key":"531_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ohc.2004.07.002","volume":"18","author":"AD Singh","year":"2005","unstructured":"Singh AD, Bergman L, Seregard S. Uveal melanoma: epidemiologic aspects. Ophthalmol Clin N Am. 2005;18:75\u201384. viii.","journal-title":"Ophthalmol Clin N Am"},{"key":"531_CR2","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10555-017-9663-3","volume":"36","author":"A Amaro","year":"2017","unstructured":"Amaro A, Gangemi R, Piaggio F, Angelini G, Barisione G, Ferrini S, et al. The biology of uveal melanoma. Cancer Metastasis Rev. 2017;36:109\u201340.","journal-title":"Cancer Metastasis Rev"},{"key":"531_CR3","doi-asserted-by":"crossref","unstructured":"Shields CL, Furuta M, Thangappan A, Nagori S, Mashayekhi A, Lally DR et al. Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes. Arch Ophthalmol Chic Ill. 1960. 2009;127:989\u201398.","DOI":"10.1001\/archophthalmol.2009.208"},{"key":"531_CR4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/QAD.0000000000001297","volume":"31","author":"S Kaliki","year":"2017","unstructured":"Kaliki S, Shields CL. Uveal melanoma: relatively rare but deadly cancer. Eye Lond Engl. 2017;31:241\u201357.","journal-title":"Eye Lond Engl"},{"key":"531_CR5","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/j.ophtha.2011.01.040","volume":"118","author":"AD Singh","year":"2011","unstructured":"Singh AD, Turell ME, Topham AK. Uveal melanoma: trends in incidence, treatment, and survival. Ophthalmology. 2011;118:1881\u20135.","journal-title":"Ophthalmology"},{"key":"531_CR6","doi-asserted-by":"crossref","unstructured":"Kivel\u00e4 T. The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death. BMJ Publishing Group Ltd; 2009.","DOI":"10.1136\/bjo.2008.150292"},{"key":"531_CR7","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1159\/000492391","volume":"5","author":"C Baily","year":"2019","unstructured":"Baily C, O\u2019Neill V, Dunne M, Cunningham M, Gullo G, Kennedy S, et al. Uveal Melanoma in Ireland. Ocul Oncol Pathol. 2019;5:195\u2013204.","journal-title":"Ocul Oncol Pathol"},{"key":"531_CR8","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1016\/j.ophtha.2007.01.032","volume":"114","author":"G Virgili","year":"2007","unstructured":"Virgili G, Gatta G, Ciccolallo L, Capocaccia R, Biggeri A, Crocetti E, et al. Incidence of uveal melanoma in Europe. Ophthalmology. 2007;114:2309\u201315.","journal-title":"Ophthalmology"},{"key":"531_CR9","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1016\/j.ophtha.2012.01.048","volume":"119","author":"EM Damato","year":"2012","unstructured":"Damato EM, Damato BE. Detection and time to treatment of uveal melanoma in the United Kingdom: an evaluation of 2,384 patients. Ophthalmology. 2012;119:1582\u20139.","journal-title":"Ophthalmology"},{"key":"531_CR10","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1136\/bjophthalmol-2015-306810","volume":"99","author":"MT Andreoli","year":"2015","unstructured":"Andreoli MT, Mieler WF, Leiderman YI. Epidemiological trends in uveal melanoma. Br J Ophthalmol. 2015;99:1550\u20133.","journal-title":"Br J Ophthalmol"},{"key":"531_CR11","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1002\/cncr.20866","volume":"103","author":"CC McLaughlin","year":"2005","unstructured":"McLaughlin CC, Wu X-C, Jemal A, Martin HJ, Roche LM, Chen VW. Incidence of noncutaneous melanomas in the U.S. Cancer. 2005;103:1000\u20137.","journal-title":"Cancer"},{"key":"531_CR12","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1159\/000512738","volume":"7","author":"P Manchegowda","year":"2021","unstructured":"Manchegowda P, Singh AD, Shields C, Kaliki S, Shah P, Gopal L, et al. Uveal melanoma in asians: a review. Ocul Oncol Pathol. 2021;7:159\u201367.","journal-title":"Ocul Oncol Pathol"},{"key":"531_CR13","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1136\/bjophthalmol-2019-315550","volume":"106","author":"D Xu","year":"2022","unstructured":"Xu D, Garg E, Lee K, Sakurada Y, Amphornphruet A, Phasukkijwatana N, et al. Long-term visual and anatomic outcomes of patients with peripapillary pachychoroid syndrome. Br J Ophthalmol. 2022;106:576\u201381.","journal-title":"Br J Ophthalmol"},{"key":"531_CR14","first-page":"1027","volume":"29","author":"CL Shields","year":"2015","unstructured":"Shields CL, Kaliki S, Cohen MN, Shields PW, Furuta M, Shields JA. Prognosis of uveal melanoma based on race in 8100 patients: the 2015 Doyne lecture. Eye Lond Engl. 2015;29:1027\u201335.","journal-title":"Eye Lond Engl"},{"key":"531_CR15","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1002\/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G","volume":"83","author":"AE Chang","year":"1998","unstructured":"Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1998;83:1664\u201378.","journal-title":"Cancer"},{"key":"531_CR16","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/S0161-6420(03)00077-0","volume":"110","author":"AD Singh","year":"2003","unstructured":"Singh AD, Topham A. Survival rates with uveal melanoma in the United States: 1973\u20131997. Ophthalmology. 2003;110:962\u20135.","journal-title":"Ophthalmology"},{"key":"531_CR17","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1001\/jamaophthalmol.2014.5395","volume":"133","author":"International Validation of the American Joint Committee","year":"2015","unstructured":"International Validation of the American Joint Committee. On Cancer\u2019s 7th Edition classification of Uveal Melanoma. JAMA Ophthalmol. 2015;133:376\u201383.","journal-title":"JAMA Ophthalmol"},{"key":"531_CR18","first-page":"2579","volume":"43","author":"L Bergman","year":"2002","unstructured":"Bergman L, Seregard S, Nilsson B, Ringborg U, Lundell G, Ragnarsson-Olding B. Incidence of uveal melanoma in Sweden from 1960 to 1998. Invest Ophthalmol Vis Sci. 2002;43:2579\u201383.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"531_CR19","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/0197-2456(93)90052-F","volume":"14","author":"Design","year":"1993","unstructured":"Design. Methods of a clinical trial for a rare condition: the collaborative ocular melanoma study. COMS Report No. 3. Control Clin Trials. 1993;14:362\u201391.","journal-title":"Control Clin Trials"},{"key":"531_CR20","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.brachy.2014.04.002","volume":"13","author":"CA Barker","year":"2014","unstructured":"Barker CA, Francis JH, Cohen GN, Marr BP, Wolden SL, McCormick B, et al. (106)Ru plaque brachytherapy for uveal melanoma: factors associated with local tumor recurrence. Brachytherapy. 2014;13:584\u201390.","journal-title":"Brachytherapy"},{"key":"531_CR21","doi-asserted-by":"crossref","unstructured":"Luo J, Zhang C, Yang Y, Xiu J, Zhao H, Liang C et al. Characteristics, treatments, and survival of Uveal Melanoma: a comparison between Chinese and American cohorts. Cancers. 2022;14.","DOI":"10.3390\/cancers14163960"},{"key":"531_CR22","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1001\/archinte.166.17.1907","volume":"166","author":"JN Cormier","year":"2006","unstructured":"Cormier JN, Xing Y, Ding M, Lee JE, Mansfield PF, Gershenwald JE, et al. Ethnic differences among patients with cutaneous melanoma. Arch Intern Med. 2006;166:1907\u201314.","journal-title":"Arch Intern Med"},{"key":"531_CR23","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1001\/archdermatol.2009.302","volume":"145","author":"S Hu","year":"2009","unstructured":"Hu S, Parmet Y, Allen G, Parker DF, Ma F, Rouhani P, et al. Disparity in melanoma: a trend analysis of melanoma incidence and stage at diagnosis among whites, hispanics, and blacks in Florida. Arch Dermatol. 2009;145:1369\u201374.","journal-title":"Arch Dermatol"},{"key":"531_CR24","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.ajo.2005.05.034","volume":"140","author":"D-N Hu","year":"2005","unstructured":"Hu D-N, Yu G-P, McCormick SA, Schneider S, Finger PT. Population-based incidence of uveal melanoma in various races and ethnic groups. Am J Ophthalmol. 2005;140:612\u20137.","journal-title":"Am J Ophthalmol"},{"key":"531_CR25","first-page":"186","volume":"32","author":"A Zewar","year":"2016","unstructured":"Zewar A, Nawaiseh I, Jaradat I, Khzouz J, Alrawashdeh K, Abdeen G, et al. Management and outcome of Uveal Melanoma in a single Tertiary Cancer Center in Jordan. Turk Patoloji Derg. 2016;32:186\u201392.","journal-title":"Turk Patoloji Derg"},{"key":"531_CR26","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.sjopt.2009.05.003","volume":"23","author":"AH Alsuhaibani","year":"2009","unstructured":"Alsuhaibani AH. Uveal melanoma in the Saudi Arabian population: two decades of management at the King Khaled Eye specialist hospital. Saudi J Ophthalmol off J Saudi Ophthalmol Soc. 2009;23:157\u201363.","journal-title":"Saudi J Ophthalmol off J Saudi Ophthalmol Soc"},{"key":"531_CR27","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.2147\/OPTH.S113623","volume":"10","author":"K Mahendraraj","year":"2016","unstructured":"Mahendraraj K, Lau CS, Lee I, Chamberlain RS. Trends in incidence, survival, and management of uveal melanoma: a population-based study of 7,516 patients from the Surveillance, Epidemiology, and end results database (1973\u20132012). Clin Ophthalmol Auckl NZ. 2016;10:2113\u20139.","journal-title":"Clin Ophthalmol Auckl NZ"},{"key":"531_CR28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/00004397-198202230-00007","volume":"22","author":"PK Kuo","year":"1982","unstructured":"Kuo PK, Puliafito CA, Wang KM, Liu HS, Wu BF. Uveal melanoma in China. Int Ophthalmol Clin. 1982;22:57\u201371.","journal-title":"Int Ophthalmol Clin"},{"key":"531_CR29","first-page":"41","volume":"52","author":"J Biswas","year":"2004","unstructured":"Biswas J, Kabra S, Krishnakumar S, Shanmugam MP. Clinical and histopathological characteristics of uveal melanoma in Asian indians. A study of 103 patients. Indian J Ophthalmol. 2004;52:41\u20134.","journal-title":"Indian J Ophthalmol"},{"key":"531_CR30","unstructured":"Arakelova V. Iran and the Caucasus. Encycl. Iran. Vol. XIII5 Iran X Relig. Iran\u2013Iraq V Safavid PeriodLondon N. Y. Routledge Kegan Paul ISBN 978-0-933273-93-1. 2006. p. 485\u20136."},{"key":"531_CR31","first-page":"292","volume":"26","author":"BE Damato","year":"2012","unstructured":"Damato BE, Coupland SE. Differences in uveal melanomas between men and women from the British Isles. Eye Lond Engl. 2012;26:292\u20139.","journal-title":"Eye Lond Engl"},{"key":"531_CR32","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1167\/iovs.12-10365","volume":"54","author":"O Zloto","year":"2013","unstructured":"Zloto O, Pe\u2019er J, Frenkel S. Gender differences in clinical presentation and prognosis of uveal melanoma. Invest Ophthalmol Vis Sci. 2013;54:652\u20136.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"531_CR33","doi-asserted-by":"publisher","first-page":"8076","DOI":"10.1200\/JCO.2005.02.6534","volume":"23","author":"P Rietschel","year":"2005","unstructured":"Rietschel P, Panageas KS, Hanlon C, Patel A, Abramson DH, Chapman PB. Variates of survival in metastatic uveal melanoma. J Clin Oncol off J Am Soc Clin Oncol. 2005;23:8076\u201380.","journal-title":"J Clin Oncol off J Am Soc Clin Oncol"},{"key":"531_CR34","doi-asserted-by":"publisher","first-page":"4651","DOI":"10.1167\/iovs.03-0538","volume":"44","author":"E Kujala","year":"2003","unstructured":"Kujala E, M\u00e4kitie T, Kivel\u00e4 T. Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci. 2003;44:4651\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"531_CR35","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.1002\/ijc.28625","volume":"134","author":"KD Bishop","year":"2014","unstructured":"Bishop KD, Olszewski AJ. Epidemiology and survival outcomes of ocular and mucosal melanomas: a population-based analysis. Int J Cancer. 2014;134:2961\u201371.","journal-title":"Int J Cancer"},{"key":"531_CR36","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000480640","volume":"4","author":"ME Aronow","year":"2018","unstructured":"Aronow ME, Topham AK, Singh AD. Uveal melanoma: 5-Year update on incidence, treatment, and survival (SEER 1973\u20132013). Ocul Oncol Pathol. 2018;4:145\u201351.","journal-title":"Ocul Oncol Pathol"},{"key":"531_CR37","doi-asserted-by":"publisher","first-page":"187","DOI":"10.4132\/jptm.2022.03.10","volume":"56","author":"S Kestel","year":"2022","unstructured":"Kestel S, G\u00f6\u00e7\u00fcn FPU, \u00d6\u011f\u00fct B, Erdem \u00d6. Clinicopathologic features and survival outcomes of ocular melanoma: a series of 31 cases from a tertiary university hospital. J Pathol Transl Med. 2022;56:187\u201398.","journal-title":"J Pathol Transl Med"},{"key":"531_CR38","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1001\/jamaophthalmol.2020.2254","volume":"138","author":"N Rajeshuni","year":"2020","unstructured":"Rajeshuni N, Zubair T, Ludwig CA, Moshfeghi DM, Mruthyunjaya P. Evaluation of racial, ethnic, and Socioeconomic associations with Treatment and Survival in Uveal Melanoma, 2004\u20132014. JAMA Ophthalmol. 2020;138:876\u201384.","journal-title":"JAMA Ophthalmol"},{"key":"531_CR39","doi-asserted-by":"crossref","unstructured":"Markiewicz A, Donizy P, Nowak M, Krzyzi\u0144ski M, Elas M, P\u0142onka PM et al. Amelanotic Uveal Melanomas evaluated by Indirect Ophthalmoscopy reveal Better Long-Term Prognosis Than Pigmented Primary Tumours-A single centre experience. Cancers. 2022;14.","DOI":"10.3390\/cancers14112753"},{"key":"531_CR40","doi-asserted-by":"crossref","unstructured":"The COMS randomized trial of. iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28. Arch Ophthalmol Chic Ill 1960. 2006;124:1684\u201393.","DOI":"10.1001\/archopht.124.12.1684"},{"key":"531_CR41","first-page":"1639","volume":"123","author":"M Diener-West","year":"2005","unstructured":"Diener-West M, Reynolds SM, Agugliaro DJ, Caldwell R, Cumming K, Earle JD, et al. Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: collaborative ocular Melanoma Study Group Report No. 26. Arch Ophthalmol Chic Ill 1960. 2005;123:1639\u201343.","journal-title":"Arch Ophthalmol Chic Ill 1960"},{"issue":"16","key":"531_CR42","doi-asserted-by":"publisher","first-page":"3960","DOI":"10.3390\/cancers14163960","volume":"14","author":"J Luo","year":"2022","unstructured":"Luo J, Zhang C, Yang Y, Xiu J, Zhao H, Liang C, et al. Characteristics, treatments, and survival of Uveal Melanoma: a comparison between Chinese and American cohorts. Cancers (Basel). 2022;14(16):3960.","journal-title":"Cancers (Basel)"},{"key":"531_CR43","doi-asserted-by":"crossref","unstructured":"Histopathologic characteristics of uveal melanomas in eyes enucleated from the collaborative ocular melanoma study. COMS report no. 6. Am J Ophthalmol. 1998;125(6):745\u201366.","DOI":"10.1016\/S0002-9394(98)00040-3"},{"issue":"22","key":"531_CR44","doi-asserted-by":"publisher","first-page":"8081","DOI":"10.3390\/app10228081","volume":"10","author":"G Broggi","year":"2020","unstructured":"Broggi G, Russo A, Reibaldi M, Russo D, Varricchio S, Bonfiglio V, et al. Histopathology and genetic biomarkers of Choroidal Melanoma. Appl Sci. 2020;10(22):8081.","journal-title":"Appl Sci"}],"container-title":["International Journal of Retina and Vitreous"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-024-00531-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40942-024-00531-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-024-00531-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T04:06:20Z","timestamp":1709265980000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalretinavitreous.biomedcentral.com\/articles\/10.1186\/s40942-024-00531-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,1]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["531"],"URL":"https:\/\/doi.org\/10.1186\/s40942-024-00531-x","relation":{},"ISSN":["2056-9920"],"issn-type":[{"value":"2056-9920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,1]]},"assertion":[{"value":"25 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consents were obtained from each participant for using the data. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional review board of Tehran University of Medical Sciences and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consents were obtained from each participant.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None of the authors have any proprietary interests or conflicts of interest related to this submission.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25"}}